Advisory Services Network’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Advisory Services Network’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Buy	15,111 +2,930	+24%	+$396K	0.03%	638
2026 Q1	$1.56M	Sell	12,181 -3,883	-24%	-$485K	0.02%	745
2025 Q4	$1.96M	Buy	16,064 +5,351	+50%	+$614K	0.03%	610
2025 Q3	$1.07M	Buy	10,713 +590	+6%	+$53.1K	0.02%	832
2025 Q2	$867K	Sell	10,123 -1,463	-13%	-$117K	0.01%	884
2025 Q1	$940K	Sell	11,586 -1,906	-14%	-$170K	0.02%	788
2024 Q4	$1.22M	Buy	13,492 +3,588	+36%	+$348K	0.02%	660
2024 Q3	$918K	Hold	9,904	–	–	0.02%	748
2024 Q2	$918K	Buy	9,904 +1,555	+19%	+$139K	0.02%	748
2024 Q1	$792K	Sell	8,349 -291	-3%	-$27K	0.02%	777
2023 Q4	$771K	Sell	8,640 -4,049	-32%	-$301K	0.02%	736
2023 Q3	$927K	Sell	12,689 -190	-1%	-$15.2K	0.02%	662
2023 Q2	$1.07M	Buy	12,879 +168	+1%	+$14.1K	0.03%	600
2023 Q1	$969K	Buy	12,711 +21	+0.2%	+$1.74K	0.03%	622
2022 Q4	$1.05M	Buy	12,690 +36	+0.3%	+$2.92K	0.03%	583
2022 Q3	$1M	Buy	12,654 +1,070	+9%	+$90.2K	0.04%	546
2022 Q2	$860K	Buy	11,584 +3,321	+40%	+$249K	0.03%	607
2022 Q1	$743K	Buy	8,263 +1,434	+21%	+$132K	0.02%	732
2021 Q4	$765K	Buy	+6,829	New	+$824K	0.02%	720
2021 Q3	–	Sell	-3,450	Closed	-$467K	–	3246
2021 Q2	$467K	Buy	+3,450	New	+$454K	0.01%	906
2021 Q1	–	Sell	-592	Closed	-$83K	–	2967
2020 Q4	$83K	Sell	592 -8	-1%	-$1.02K	﹤0.01%	1418
2020 Q3	$67K	Buy	+600	New	+$67.3K	﹤0.01%	1445
2020 Q2	–	Sell	-1,321	Closed	-$102K	–	2758
2020 Q1	$102K	Buy	1,321 +376	+40%	+$33.3K	0.01%	1070
2019 Q4	$90K	Sell	945 -284	-23%	-$24.6K	﹤0.01%	1207
2019 Q3	$108K	Hold	1,229	–	–	0.01%	1039
2019 Q2	$108K	Buy	1,229 +416	+51%	+$35.5K	0.01%	1037
2019 Q1	$74K	Sell	813 -927	-53%	-$78.9K	0.01%	1097
2018 Q4	$125K	Buy	1,740 +1,524	+706%	+$123K	0.01%	828
2018 Q3	$21K	Buy	216 +2	+0.9%	+$194	﹤0.01%	1560
2018 Q2	$21K	Buy	214 +42	+24%	+$3.86K	﹤0.01%	1538
2018 Q1	$15K	Sell	172 -169	-50%	-$15.4K	﹤0.01%	1749
2017 Q4	$29K	Sell	341 -458	-57%	-$38.4K	﹤0.01%	1493
2017 Q3	$69K	Sell	799 -97	-11%	-$7.78K	0.01%	990
2017 Q2	$69K	Buy	896 +752	+522%	+$53.3K	0.01%	954
2017 Q1	$10K	Buy	+144	New	+$9.67K	﹤0.01%	1485
2016 Q3	$4K	Hold	60	–	–	﹤0.01%	1624
2016 Q2	$3K	Buy	+60	New	+$3.29K	﹤0.01%	1594

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Advisory Services Network's XBI Position: Q2 2026 in Review

Advisory Services Network increased its State Street SPDR S&P Biotech ETF (XBI) stake by 24% in Q2 2026, buying an estimated $396K and bringing the position to 15,111 shares worth $2.39M. The position accounts for 0.03% of the portfolio, ranked #638.

Advisory Services Network first reported a position in XBI in Q2 2016 and has held it in 37 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Advisory Services Network held 15,111 shares of State Street SPDR S&P Biotech ETF worth $2.39M as of Q2 2026.
Advisory Services Network bought 2,930 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $396K.
State Street SPDR S&P Biotech ETF made up 0.03% of Advisory Services Network's portfolio in Q2 2026, its #638 holding.
Advisory Services Network first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and has held it in 37 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.